Weifeng Huang

978 total citations
38 papers, 787 citations indexed

About

Weifeng Huang is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Weifeng Huang has authored 38 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Pharmacology and 7 papers in Epidemiology. Recurrent topics in Weifeng Huang's work include Drug-Induced Hepatotoxicity and Protection (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Weifeng Huang is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Weifeng Huang collaborates with scholars based in China, United States and Pakistan. Weifeng Huang's co-authors include Chunpeng Wan, Weifang Li, Kang Yang, Qi Luo, Qicong Luo, Zhigang Mei, Kuancan Liu, Muhammad Nisar, Liangliang Yao and Zhengjie Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Weifeng Huang

35 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Huang China 17 351 144 137 102 97 38 787
Amro El‐Karef Egypt 16 236 0.7× 164 1.1× 174 1.3× 59 0.6× 82 0.8× 24 681
Sun‐Mi Yun South Korea 17 484 1.4× 104 0.7× 79 0.6× 97 1.0× 54 0.6× 35 855
Lawrence Owusu China 16 466 1.3× 66 0.5× 84 0.6× 65 0.6× 79 0.8× 26 877
Yijie Li China 19 297 0.8× 88 0.6× 127 0.9× 83 0.8× 42 0.4× 86 830
Beihui He China 15 351 1.0× 85 0.6× 335 2.4× 82 0.8× 63 0.6× 43 863
Zhongmei Wen China 17 708 2.0× 140 1.0× 104 0.8× 198 1.9× 47 0.5× 28 1.2k
Jui‐Chieh Chen Taiwan 16 298 0.8× 63 0.4× 157 1.1× 96 0.9× 71 0.7× 35 731
Yingchun Zhou China 23 619 1.8× 145 1.0× 99 0.7× 155 1.5× 79 0.8× 67 1.2k
Xuemei Gu China 17 390 1.1× 112 0.8× 236 1.7× 69 0.7× 88 0.9× 40 1.0k
Qionghui Huang China 16 328 0.9× 164 1.1× 89 0.6× 35 0.3× 84 0.9× 32 718

Countries citing papers authored by Weifeng Huang

Since Specialization
Citations

This map shows the geographic impact of Weifeng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Huang more than expected).

Fields of papers citing papers by Weifeng Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Huang. The network helps show where Weifeng Huang may publish in the future.

Co-authorship network of co-authors of Weifeng Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Huang. A scholar is included among the top collaborators of Weifeng Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Huang. Weifeng Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Weifeng, Dingjie Wang, Yuan Ren, et al.. (2025). Prognostic assessment of cervical cancer based on biomarkers: the interaction of ERRα and immune microenvironment. Virology Journal. 22(1). 47–47.
2.
Zhang, Yin, et al.. (2025). Caffeic acid ameliorates intestinal barrier injury to attenuate acute pancreatitis via inhibiting GSDMD-mediated pyroptotic pathway. Journal of Ethnopharmacology. 353(Pt A). 120261–120261.
3.
Huang, Weifeng, et al.. (2025). ANGPTL4 induces Kupffer cell M2 polarization to mitigate acute rejection in liver transplantation. Scientific Reports. 15(1). 986–986. 4 indexed citations
4.
Huang, Weifeng, Michelle Cao, Simin Li, et al.. (2024). Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches. Scientific Reports. 14(1). 26432–26432. 3 indexed citations
5.
Wang, Xiaohan, Ji‐Xiao Zhu, Weifeng Huang, et al.. (2024). Blueberry extract attenuates DSS-induced inflammatory bowel disease in mice through inhibiting ER stress-mediated colonic apoptosis in mice. Food & Function. 15(18). 9541–9551. 4 indexed citations
6.
Song, Li, Ding Zhang, Hankun Wang, et al.. (2024). Automated quantitative assay of fibrosis characteristics in tuberculosis granulomas. Frontiers in Microbiology. 14. 1301141–1301141. 3 indexed citations
7.
8.
Tsun, Andy, Tianhang Zhai, Weifeng Huang, et al.. (2021). 895 Discovery of a safer 4–1BB agonist by targeting a membrane-proximal epitope combined with bispecific-mediated cross-bridging. SHILAP Revista de lepidopterología. A939–A939. 1 indexed citations
9.
Wang, Linpei, et al.. (2020). Genistein protects against acetaminophen-induced liver toxicity through augmentation of SIRT1 with induction of Nrf2 signalling. Biochemical and Biophysical Research Communications. 527(1). 90–97. 20 indexed citations
10.
Wang, Jing, et al.. (2020). Sedum sarmentosum Total Flavonoids Alleviate Schistosomiasis‐Induced Liver Fibrosis by Altering TGF‐β1 and Smad7 Expression. Evidence-based Complementary and Alternative Medicine. 2020(1). 2083697–2083697. 6 indexed citations
11.
Yan, Tingdong, et al.. (2019). The Beneficial Roles of SIRT1 in Drug-Induced Liver Injury. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 49 indexed citations
12.
Huang, Weifeng, et al.. (2018). Phytochemical and Pharmacological Properties of Chaenomeles speciosa : An Edible Medicinal Chinese Mugua. Evidence-based Complementary and Alternative Medicine. 2018(1). 9591845–9591845. 24 indexed citations
13.
Wei, Tao, Songbai Yang, Jinfeng Wang, et al.. (2018). The Antiapoptosis Effect of Geum japonicum Thunb. var. chinense Extracts on Cerebral Ischemia Reperfusion Injury via PI3K/Akt Pathway. Evidence-based Complementary and Alternative Medicine. 2018(1). 7290170–7290170. 16 indexed citations
14.
Huang, Weifeng, Liangliang Yao, Lei Wang, et al.. (2018). Hypoglycemic activity and constituents analysis of blueberry (<em>Vaccinium corymbosum</em>) fruit extracts. Diabetes Metabolic Syndrome and Obesity. Volume 11. 357–366. 19 indexed citations
15.
Mei, Zhigang, et al.. (2017). Fermented Chinese formula Shuan-Tong-Ling attenuates ischemic stroke by inhibiting inflammation and apoptosis. Neural Regeneration Research. 12(3). 425–425. 37 indexed citations
16.
Yang, Kang, et al.. (2017). Diosmetin protects against ischemia/reperfusion-induced acute kidney injury in mice. Journal of Surgical Research. 214. 69–78. 51 indexed citations
17.
Liu, Kuancan, Rui Zhang, Long Zhang, et al.. (2017). SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis. Molecular Cancer. 16(1). 62–62. 85 indexed citations
18.
Zhang, Xiang, Zhigang Mei, Jinfeng Wang, et al.. (2016). Fermented Chinese Formula Shuan‐Tong‐Ling Protects Brain Microvascular Endothelial Cells against Oxidative Stress Injury. Evidence-based Complementary and Alternative Medicine. 2016(1). 5154290–5154290. 19 indexed citations
19.
Huang, Weifeng, et al.. (2014). Sodium houttuyfonate and EDTA-Na2 in combination effectively inhibits Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans in vitro and in vivo. Bioorganic & Medicinal Chemistry Letters. 25(1). 142–147. 29 indexed citations
20.
Huang, Weifeng, et al.. (2009). Effect of quercetin on colon contractility and L-type Ca(2+) channels in colon smooth muscle of guinea-pig.. PubMed. 61(6). 567–76. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amro El‐Karef Breakdown of academic impact, for papers by Sun‐Mi Yun Breakdown of academic impact, for papers by Lawrence Owusu Breakdown of academic impact, for papers by Yijie Li Breakdown of academic impact, for papers by Beihui He Breakdown of academic impact, for papers by Zhongmei Wen Breakdown of academic impact, for papers by Jui‐Chieh Chen Breakdown of academic impact, for papers by Yingchun Zhou Breakdown of academic impact, for papers by Xuemei Gu Breakdown of academic impact, for papers by Qionghui Huang
Rankless by CCL
2026